Currently, the levels of HDL-C and ApoA-I are measured with very good precision and accuracy in all clinical laboratories, so the use of the HDL-C/ApoA-I index would provide additional information to estimate the probability of subclinical atherosclerosis. The gene discussed is APOA1; the disease is atherosclerosis.